Literature DB >> 32810447

The tumor microenvironment.

Nicole M Anderson1, M Celeste Simon2.   

Abstract

A tumor is not simply a group of cancer cells, but rather a heterogeneous collection of infiltrating and resident host cells, secreted factors and extracellular matrix. Tumor cells stimulate significant molecular, cellular and physical changes within their host tissues to support tumor growth and progression. An emerging tumor microenvironment is a complex and continuously evolving entity. The composition of the tumor microenvironment varies between tumor types, but hallmark features include immune cells, stromal cells, blood vessels, and extracellular matrix. It is believed that the "tumor microenvironment is not just a silent bystander, but rather an active promoter of cancer progression" (Truffi et al., 2020). Early in tumor growth, a dynamic and reciprocal relationship develops between cancer cells and components of the tumor microenvironment that supports cancer cell survival, local invasion and metastatic dissemination. To overcome a hypoxic and acidic microenvironment, the tumor microenvironment coordinates a program that promotes angiogenesis to restore oxygen and nutrient supply and remove metabolic waste. Tumors become infiltrated with diverse adaptive and innate immune cells that can perform both pro- and anti- tumorigenic functions (Figure 1). An expanding literature on the tumor microenvironment has identified new targets within it for therapeutic intervention.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Year:  2020        PMID: 32810447     DOI: 10.1016/j.cub.2020.06.081

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  165 in total

Review 1.  Radionuclide imaging and therapy directed towards the tumor microenvironment: a multi-cancer approach for personalized medicine.

Authors:  Circe D van der Heide; Simone U Dalm
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-07-05       Impact factor: 9.236

2.  Tumor-Associated Macrophages: Reasons to Be Cheerful, Reasons to Be Fearful.

Authors:  Izabela Szulc-Kielbik; Michal Kielbik
Journal:  Exp Suppl       Date:  2022

3.  Humanized Patient-Derived Xenograft Models of Ovarian Cancer.

Authors:  Sarah B Gitto; Erin George; Sergey Medvedev; Fiona Simpkins; Daniel J Powell
Journal:  Methods Mol Biol       Date:  2022

Review 4.  The plasticity of mRNA translation during cancer progression and therapy resistance.

Authors:  Lucilla Fabbri; Alina Chakraborty; Caroline Robert; Stéphan Vagner
Journal:  Nat Rev Cancer       Date:  2021-08-02       Impact factor: 60.716

Review 5.  The enteric nervous system in gastrointestinal disease etiology.

Authors:  Amy Marie Holland; Ana Carina Bon-Frauches; Daniel Keszthelyi; Veerle Melotte; Werend Boesmans
Journal:  Cell Mol Life Sci       Date:  2021-03-26       Impact factor: 9.261

6.  Relationship between Tertiary Lymphoid Structure and the Prognosis and Clinicopathologic Characteristics in Solid Tumors.

Authors:  Zhan Zhao; Hui Ding; Zheng-Bin Lin; Sheng-Hui Qiu; Yi-Ran Zhang; Yan-Guan Guo; Xiao-Dong Chu; Loi I Sam; Jing-Hua Pan; Yun-Long Pan
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

Review 7.  Application of Nano-Drug Delivery System Based on Cascade Technology in Cancer Treatment.

Authors:  Ying Sun; Xiaoli Ma; Hao Hu
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

8.  Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients.

Authors:  Chengcheng Qian; Renjie Cai; Wenying Zhang; Jiongyi Wang; Xiaohua Hu; Yanjie Zhang; Bin Jiang; Haihua Yuan; Feng Liu
Journal:  Front Oncol       Date:  2021-07-07       Impact factor: 6.244

Review 9.  RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.

Authors:  Texali C Garcia-Garduño; Jorge R Padilla-Gutierrez; Diego Cambrón-Mora; Yeminia Valle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

10.  Pan-cancer characterization of lncRNA modifiers of immune microenvironment reveals clinically distinct de novo tumor subtypes.

Authors:  Zicheng Zhang; Congcong Yan; Ke Li; Siqi Bao; Lei Li; Lu Chen; Jingting Zhao; Jie Sun; Meng Zhou
Journal:  NPJ Genom Med       Date:  2021-06-17       Impact factor: 8.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.